259
Views
36
CrossRef citations to date
0
Altmetric
Research Article

The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts

&
Pages 482-491 | Published online: 08 Jul 2009

References

  • Cohen DE. Pathogenesis of gallstones. In: Zakim D, Boyer TD, editors. Hepatology: a textbook of liver disease. 4th edn. Philadelphia: Saunders; 2003:1713–43.
  • Chiang JY. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 2002;23:443–63.
  • Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003;72:137–74.
  • Stravitz RT, Vlahcevic ZR, Gurley EC, Hylemon PB. Repression of cholesterol 7a-hydroxylase transcription by bile acids is mediated through protein kinase C in primary cultures of rat hepatocytes. J Lipid Res 1995;36:1359–69.
  • Miyake JH, Wang SL, Davis RA. Bile acid induction of cytokine expression by macrophages correlates with repres-sion of hepatic cholesterol 7a-hydroxylase. J Biol Chem 2000; 275:21805–8.
  • Gupta S, Stravitz RT, Dent P, Hylemon PB. Down-regulation of cholesterol 7a-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c- Jun N-terminal kinase pathway. J Biol Chem 2001;276:15816–22.
  • Qiao L, Han SI, Fang Y, Park JS, Gupta S, Gilfor D, et al. Bile acid regulation of C/EBPb, CREB, and c- Jun function, via the extracellular signal-regulated kinase and c- Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol Cell Biol 2003;23:3052–66.
  • Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science 1999;284:1362–5.
  • Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999;284:1365–8.
  • Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999;3:543–53.
  • Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 1995;81:687–93.
  • Seol W, Choi HS, Moore DD. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol Endocrinol 1995;9:72–85.
  • Huber RM, Murphy K, Miao B, Link JR, Cunningham MR, Rupar MJ, et al. Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. Gene 2002; 290:35–43.
  • Zhang Y, Kast-Woelbern HR, Edwards PA. Natural structur-al variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. J Biol Chem 2003;278:104–10.
  • Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA. Peroxisome proliferator-activated receptor-g coactivator la (PGC-1a) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 2004;18: 157–69.
  • Mi LZ, Devarakonda S, Harp JM, Han Q, Pellicciari R, Willson TM, et al. Structural basis for bile acid binding and activation of the nuclear receptor FXR. Mol Cell 2003; 11: 1093–100.
  • Downes M, Verdecia MA, Roecker AJ, Hughes R, Hogenesch JB, Kast-Woelbern HR, et al. A chemical, genetic, and struc-tural analysis of the nuclear bile acid receptor FXR. Mol Cell 2003;11:1079–92.
  • Otte K, Kranz H, Kober I, Thompson P, Hoefer M, Haubold B, et al. Identification of farnesoid X receptor b as a novel mammalian nuclear receptor sensing lanosterol. Mol Cell Biol 2003;23:864–72.
  • Falany CN, Johnson MR, Barnes S, Diasio RB. Glycine and taurine conjugation of bile acids by a single enzyme. Molecu-lar cloning and expression of human liver bile acid CoA: amino acid N-acyltransferase. J Biol Chem 1994;269:19375–9.
  • Steinberg SJ, Mihalik SJ, Kim DG, Cuebas DA, Watkins PA. The human liver-specific homolog of very long-chain acyl-CoA synthetase is cholate:CoA ligase. J Biol Chem 2000;275: 15605–8.
  • Pircher PC, Kitto JL, Petrowski ML, Tangirala RK, Bischoff ED, Schulman IG, et al. Farnesoid X receptor regulates bile acid-amino acid conjugation. J Biol Chem 2003;278:27703–11.
  • Falany CN, Comer KA, Dooley TP, Glatt H. Human de-hydroepiandrosterone sulfotransferase. Purification, molecu-lar cloning, and characterization. Ann NY Acad Sci 1995;774: 59–72.
  • Pillot T, Ouzzine M, Fournel-Gigleux S, Lafaurie C, Rado-minska A, Burchell B, et al. Glucuronidation of hyodeoxy-cholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem 1993; 268: 25636–42.
  • Song CS, Echchgadda I, Baek BS, Ahn SC, Oh T, Roy AK, et al. Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J Biol Chem 2001; 276:42549–56.
  • Barbier 0, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, et al. FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 2003;124: 1926–40.
  • Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002;71:537–92.
  • Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C, et al. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 2001; 276: 39411–8.
  • Plass JR, Mol 0, Heegsma J, Geuken M, Faber KN, Jansen PL, et al. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 2002;35:589–96.
  • Huang L, Zhao A, Lew JL, Zhang T, Hrywna Y, Thompson JR, et al. Farnesoid X-receptor activates transcription of the phospholipid pump MDR3. J Biol Chem 2003;278:51085–90.
  • Oude Elferink R. Cholestasis. Gut 2003;52:ii42–8.
  • Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastro-enterology 2004;126:322–42.
  • Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, et al. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 2002;277:2908–15.
  • Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000;6:517–26.
  • Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000;6:507–15.
  • Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000; 102:731–44.
  • Brendel C, Schoonjans K, Botrugno OA, Treuter E, Auwerx J. The small heterodimer partner interacts with the liver X receptor a and represses its transcriptional activity. Mol Endocrinol 2002;16:2065–76.
  • Kerr TA, Saeki S, Schneider M, Schaefer K, Berdy S, Redder T, et al. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell 2002;2:713–20.
  • Wang L, Lee YK, Bundman D, Han Y, Thevananther S, Kim CS, et al. Redundant pathways for negative feedback regu-lation of bile acid production. Dev Cell 2002;2:721–31.
  • Denson LA, Sturm E, Echevarria W, Zimmerman TL, Makishima M, Mangelsdorf DJ, et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 2001;121:140–7.
  • del Castillo-Olivares A, Gil G. Suppression of sterol 12a-hydroxylase transcription by the short heterodimer partner: insights into the repression mechanism. Nucleic Acids Res 2001;29: 4035–42.
  • Chen F, Ma L, Dawson PA, Sinal CJ, Sehayek E, Gonzalez FJ, et al. Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J Biol Chem 2003;278:19909–16.
  • Lazaridis KN, Tietz P, Wu T, Kip S, Dawson PA, LaRusso NF. Alternative splicing of the rat sodium/bile acid trans-porter changes its cellular localization and transport proper-ties. Proc Natl Acad Sci USA 2000;97:11092–7.
  • Inokuchi A, Hinoshita E, Iwamoto Y, Kohno K, Kuwano M, Uchiumi T. Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter. J Biol Chem 2001;276:46822–9.
  • Bohan A, Chen WS, Denson LA, Held MA, Boyer JL. Tumor necrosis factor a-dependent up-regulation of Lrh-1 and Mrp3 (Abcc3) reduces liver injury in obstructive cholestasis. J Biol Chem 2003;278: 36688–98.
  • Grober J, Zaghini I, Fujii H, Jones SA, Kliewer SA, Willson TM, et al. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor hetero-dimer. J Biol Chem 1999;274:29749–54.
  • Kok T, Hulzebos CV, Wolters H, Havinga R, Agellon LB, Stellaard F, et al. Enterohepatic circulation of bile salts in FXR-deficient mice: Efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein (Ibabp). J Biol Chem 2003;278:41930–7.
  • Zhao A, Lew JL, Huang L, Yu J, Zhang T, Hrywna Y, et al. Human kininogen gene is transactivated by the farnesoid X receptor. J Biol Chem 2003;278:28765–70.
  • Sharma JN, Uma K, Noor AR, Rahman AR. Blood pressure regulation by the kallikrein-kinin system. Gen Pharmacol 1996;27:55–63.
  • St-Pierre MV, Kullak-Ublick GA, Hagenbuch B, Meier PJ. Transport of bile acids in hepatic and non-hepatic tissues. J Exp Biol 2001;204:1673–86.
  • Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF, et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 2003;17:1581–91.
  • Chen F, Ananthanarayanan M, Emre S, Neimark E, Bull LN, Knisely AS, et al. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 2004;126:756–64.
  • Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997;272:3137–40.
  • Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRa. Cell 1998;93:693–704.
  • Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA. Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-a. Mol Endocrinol 2003;17:386–94.
  • Chen W, Owsley E, Yang Y, Stroup D, Chiang JY. Nuclear receptor-mediated repression of human cholesterol 7a-hydro-xylase gene transcription by bile acids. J Lipid Res 2001;42: 1402–12.
  • Zhang M, Chiang JY. Transcriptional regulation of the human sterol 12a-hydroxylase gene (CYP8B1): roles of hepatocyte nuclear factor 4a in mediating bile acid repression. J Biol Chem 2001;276:41690–9.
  • Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 2001;98:3369–74.
  • Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 2001;98:3375–80.
  • Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002;296:1313–6.
  • Yu J, Lo JL, Huang L, Zhao A, Metzger E, Adams A, et al. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem 2002;277:31441–7.
  • Kishida T, Taguchi F, Feng L, Tatsuguchi A, Sato J, Fujimori S, et al. Analysis of bile acids in colon residual liquid or fecal material in patients with colorectal neoplasia and control subjects. J Gastroenterol 1997;32:306–11.
  • Crocenzi FA, Mottino AD, Sanchez Pozzi EJ, Pellegrino JM, Rodriguez Garay EA, Milkiewicz P, et al. Impaired locali-sation and transport function of canalicular Bsep in tauro-lithocholate induced cholestasis in the rat. Gut 2003; 52: 1170–7.
  • Staudinger J, Liu Y, Madan A, Habeebu S, Klaassen CD. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos 200129:1467–72.
  • Guo GL, Staudinger J, Ogura K, Klaassen CD. Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16a-carbonitrile is via interaction with pregnane X receptor. Mol Pharmacol 2002;61:832–9.
  • Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB, Jr, Kliewer SA, et al. Complementary roles of Farnesoid X receptor, pregnane X receptor, and constitutive Androstane receptor in protection against bile acid toxicity. J Biol Chem 2003;278:45062–45071.
  • Assem M, Schuetz EG, Leggas M, Sun D, Yasuda K, Reid G, et al. Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J Biol Chem 2004;279:22250–7.
  • Saini SP, Sonoda J, Xu L, Toma D, Uppal H, Mu Y, et al. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol Phar-macol 2004;65:292–300.
  • Sonoda J, Xie W, Rosenfeld JM, Barwick JL, Guzelian PS, Evans RM. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci USA 2002;99:13801–6.
  • Stravitz RT, Rao YP, Vlahcevic ZR, Gurley EC, Jarvis WD, Hylemon PB. Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7a-hydroxylase. Am J Physiol 1996;271:G293–303.
  • Feingold KR, Spady DK, Pollock AS, Moser AH, Grunfeld C. Endotoxin, TNF, and IL-1 decrease cholesterol 7a-hydro-xylase mRNA levels and activity. J Lipid Res 1996;37: 223–8.
  • De Fabiani E, Mitro N, Anzulovich AC, Pinelli A, Galli G, Crestani M. The negative effects of bile acids and tumor necrosis factor-a on the transcription of cholesterol 7a-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 2001;276:30708–16.
  • Pellicciari R, Fiorucci S, Camaioni E, Clerici C, Costantino G, Maloney PR, et al. 6a-ethyl-chenodeoxycholic acid (6-ECD-CA), a potent and selective FXR agonist endowed with anticholestatic activity. J Med Chem 2002;45:3569–72.
  • Maloney PR, Parks DJ, Haffner CD, Fivush AM, Chandra G, Plunket KD, et al. Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem 2000;43:2971–4.
  • Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 2003;112:1678–87.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.